Sonoma Pharma Announces U.S. Commercialization Of Loyon For Relief Of Scaling, Burning And Itching Associated With Various Dermatoses Including Seborrhea And Seborrheic Dermatitis Post author:Sam Post published:October 2, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Tiny Parion Sciences Seals Dry Eye Drug Deal Worth $535 Million With Biotech Giant Shire April 30, 2017 Encision, Inc. Reports Third Quarter Fiscal Year 2017 Results; Sequential Quarterly Revenue Grows 4 Percent February 7, 2017 FDA Calls Regeneron, Sanofi Carcinoma Drug a Breakthrough September 7, 2017
Tiny Parion Sciences Seals Dry Eye Drug Deal Worth $535 Million With Biotech Giant Shire April 30, 2017
Encision, Inc. Reports Third Quarter Fiscal Year 2017 Results; Sequential Quarterly Revenue Grows 4 Percent February 7, 2017